Reneuron Group Plc

Reneuron Group Plc company information, Employees & Contact Information

ReNeuron is a biotechnology company harnessing the natural biology of exosomes to develop next-generation drug delivery systems. With deep roots in stem cell research, we are uniquely positioned to advance exosome technologies into clinically meaningful solutions.

Company Details

Employees
27
Address
Belgrave House, 39-43 Monument Hill,united Kingdom
Phone
+44 1483 302560
Email
in****@****ron.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Oxford.
HQ
Bridgend, -Please select-
Looking for a particular Reneuron Group Plc employee's phone or email?

Reneuron Group Plc Questions

News

PLC emerges from year-long administration as private company - BusinessCloud

PLC emerges from year-long administration as private company BusinessCloud

ReNeuron transitions to private company post-administration By Investing.com - Investing.com UK

ReNeuron transitions to private company post-administration By Investing.com Investing.com UK

ReNeuron joins exodus from AIM exchange after missing fundraising goal - Fierce Biotech

ReNeuron joins exodus from AIM exchange after missing fundraising goal Fierce Biotech

ReNeuron’s hRPC stem cell therapy yields positive results - Clinical Trials Arena

ReNeuron’s hRPC stem cell therapy yields positive results Clinical Trials Arena

ReNeuron and StemCells get green light for neural stem cell trials - Nature

ReNeuron and StemCells get green light for neural stem cell trials Nature

ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy - SelectScience

ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy SelectScience

UK biotech ReNeuron quits AIM as financing push fails - pharmaphorum

UK biotech ReNeuron quits AIM as financing push fails pharmaphorum

Positive Phase IIa stroke clinical data for ReNeuron’s CTX - The Pharma Letter

Positive Phase IIa stroke clinical data for ReNeuron’s CTX The Pharma Letter

ReNeuron aiming to take second stem cell therapy into clinic - PMLiVE

ReNeuron aiming to take second stem cell therapy into clinic PMLiVE

First Patient Receives ReNeuron’s Neural Stem Cell Therapy - Genetic Engineering and Biotechnology News

First Patient Receives ReNeuron’s Neural Stem Cell Therapy Genetic Engineering and Biotechnology News

ReNeuron green light for new clinical trial - Proactive financial news

ReNeuron green light for new clinical trial Proactive financial news

Sprouting a career in regenerative medicine - Science | AAAS

Sprouting a career in regenerative medicine Science | AAAS

ReNeuron may have a future as a listed company, investors and creditors told - Proactive Investors

ReNeuron may have a future as a listed company, investors and creditors told Proactive Investors

ReNeuron stem cell test helps mobility in stroke patients but misses endpoint - Fierce Biotech

ReNeuron stem cell test helps mobility in stroke patients but misses endpoint Fierce Biotech

Biotech firm Reneuron becomes latest to quit AIM as it battles for survival - City AM

Biotech firm Reneuron becomes latest to quit AIM as it battles for survival City AM

ReNeuron (RENE) Shares Rallied 8.2%, Completing Their Recovery From the Recent Crash - AskTraders.com

ReNeuron (RENE) Shares Rallied 8.2%, Completing Their Recovery From the Recent Crash AskTraders.com

[Withdrawn] Regenerative medicine: a new therapy for stroke patients - GOV.UK

[Withdrawn] Regenerative medicine: a new therapy for stroke patients GOV.UK

Angel Biotech to Conduct Development and Manufacturing for ReNeuron’s Stem Cell Program - Genetic Engineering and Biotechnology News

Angel Biotech to Conduct Development and Manufacturing for ReNeuron’s Stem Cell Program Genetic Engineering and Biotechnology News

ReNeuron boosted after reaching regulatory milestone - Wales Online

ReNeuron boosted after reaching regulatory milestone Wales Online

Company given millions of Welsh public money falls into administration - Wales Online

Company given millions of Welsh public money falls into administration Wales Online

Pioneering stem cell therapy firm ReNeuron signs deal to bring UK's most hi-tech commercial site to Wales - Wales Online

Pioneering stem cell therapy firm ReNeuron signs deal to bring UK's most hi-tech commercial site to Wales Wales Online

ReNeuron Group (OTCMKTS:RNUGF) versus ProKidney (NASDAQ:PROK) Financial Analysis - Defense World

ReNeuron Group (OTCMKTS:RNUGF) versus ProKidney (NASDAQ:PROK) Financial Analysis Defense World

Top Reneuron Group Plc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant